A Finnish healthtech startup just handed a massive lifeline to overworked oncologists worldwide. Helsinki based Gosta Labs has successfully raised €7.5 million in seed funding to scale its artificial intelligence operating system designed specifically for complex medical fields. The company aims to fix the broken administrative infrastructure of cancer care so doctors can focus on saving lives.
Voima Ventures led the investment round.
They were joined by COR Group and the Aho family along with other strategic angel investors. This latest financial injection follows a successful €1.7 million pre-seed round raised in 2024. Gosta Labs has now secured nearly €10 million in total funding to date. The capital will fuel the global expansion of their platform which promises to cut clinical documentation time drastically.
Funding Backs a Proven Leadership Team
Investors are betting big on the team behind the technology as much as the product itself. The company was founded in 2023 by Lauri Sippola and Henri Viertolahti.
These are not new names in the digital health sector.
The duo previously founded Kaiku Health which became a global standard in patient monitoring before its acquisition by Elekta in 2020. Their track record of building regulated health solutions that actually work at a global scale has instilled deep confidence in the market.
AI medical software interface on tablet with doctor background
The leadership team combines technical AI expertise with serious medical credentials.
Key executives include Dr. Lionel Hadjadjeba as Chief Medical Officer and Reetta Arokoski as Chief Operating Officer. Both bring decades of experience in scaling medical technologies across international borders. This blend of clinical knowledge and software scalability is rare in the healthtech space.
Here is a breakdown of the key stakeholders in this round:
- Lead Investor: Voima Ventures (Known for backing deep tech science startups)
- Strategic Partners: COR Group and the Aho Family
- Returning Investors: Reaktor
- Total Funding to Date: Approximately €10 million
The influx of cash will allow the team to hire top talent. It will also accelerate the deployment of their “medical-device-grade” product to hospitals that are currently drowning in data.
The Growing Crisis in Global Oncology
The timing of this technology could not be more critical for the healthcare industry. Cancer care is facing a perfect storm of rising case numbers and shrinking resources.
Recent studies project that by 2050 there will be over 35 million new cancer cases annually.
This explosion in patient numbers involves over 100 different cancer types which makes diagnosis and treatment highly complex. Medical teams are already stretched thin. Clinicians currently spend hours every single day typing notes into fragmented systems rather than seeing patients.
The data problem is severe:
- Most clinical data is unstructured text.
- Information is trapped in silos.
- Guidelines change rapidly.
This administrative burden leads to physician burnout. It also creates risks for patients when critical information gets lost in the noise. Multidisciplinary teams need to make high stakes decisions quickly. They cannot afford to waste time hunting for data across different software platforms. Gosta Labs is attacking this exact bottleneck.
How the AI Operating System Works
Gosta Labs is not just building another chatbot or a simple transcription tool. They have developed a comprehensive AI operating system (OS) that acts as an intelligent layer on top of existing hospital workflows.
The system functions in real time during patient consultations.
It converts the conversation and clinical observations into high quality structured data immediately. This means the system does not just record what was said. It understands the medical context. It categorizes the information according to international standards and institutional requirements automatically.
The software creates a visual summary of the patient journey.
This visualization helps doctors grasp the full history of a patient in seconds rather than minutes. It also automates the tedious process of clinical documentation.
Key features of the OS include:
- Real-time Documentation: Generates notes structured to hospital standards instantly.
- Quality Assurance: Assesses clinical parameters against treatment pathways.
- Guideline Linking: Automatically connects decisions to international medical protocols.
- Safety Checks: Classifies toxicity grades and patient performance status without manual input.
By handling the “digital paperwork,” the AI allows the oncologist to look the patient in the eye instead of staring at a computer screen. This restores the human connection that is often lost in modern medicine.
Promising Results from Early Adopters
The medical community is notoriously skeptical of new tech but the early data from Gosta Labs is turning heads. The company presented its first real world results at the prestigious ESMO 2025 Congress.
The findings were significant for hospital administrators and clinicians alike.
Oncologists using the system completed follow up visit documentation in a median time of under two minutes.
This is a massive reduction compared to the standard workflow. Saving even five minutes per patient can add up to hours of saved time per week for a busy specialist. This efficiency does not come at the cost of quality.
The study showed that the automated notes were high quality and structured correctly. The system successfully classified complex metrics like CTCAE toxicity grades which are essential for tracking side effects in cancer therapy.
| Metric | Gosta Labs AI Result | Impact |
|---|---|---|
| Documentation Time | Under 2 minutes (median) | Reduces burnout |
| Data Structure | Standardized instantly | Better research data |
| Clinical Accuracy | High compliance | Safer patient care |
These results validate the technology as a viable tool for daily clinical practice. It proves that AI can handle the nuance required in oncology. The success at ESMO 2025 likely played a major role in securing this fresh round of capital.
Improving Personalized Care Globally
The ultimate goal of Gosta Labs goes beyond just saving time for doctors. The broader mission is to enable true personalized medicine at a global scale.
Every patient journey in cancer care is unique.
Treatments are becoming more specialized. Therapies that work for one genetic profile may not work for another. To deliver this level of precision care doctors need structured data. They need to know exactly what has happened at every stage of treatment.
Structured data enables better decision making.
When clinical notes are just blocks of text it is hard to analyze trends. When that data is structured by an AI OS it becomes a powerful asset. Hospitals can track outcomes better. Researchers can identify patterns faster. Patients receive care that is more consistent and aligned with the latest global guidelines.
The €7.5 million seed funding ensures that Gosta Labs can push this vision forward. They plan to expand the reach of their AI assistant to oncology teams around the world. The focus remains on building a safe and regulated foundation that hospitals can trust.
By reducing the administrative load the company is giving time back to care teams. In the fight against cancer time is the most valuable resource of all.
